CMMB

Chemomab Therapeutics Ltd

• NASDAQ·1d ago

  Top Biotech Gainers: AKTX Rallies; GOVX Up On Ebola Concerns; SLGL Awaits Catalysts; CMMB On Watch

• TipRanks·05/19 18:55

  Okunewitch Reiterates Buy on Emerging Nebokitug Data and Solid Cash Runway; Price Target Maintained at $5

• TipRanks·05/15 11:57

  Chemomab Therapeutics (CMMB) Receives a Buy from Oppenheimer

• Seeking Alpha·05/14 18:33

  Chemomab Therapeutics GAAP EPS of $0.00

• TipRanks·05/14 12:27

  Chemomab Highlights New Nebokitug Data in PSC as Q1 2026 Update Underscores PSC–IBD Potential

• PUBT·05/14 12:01

  Chemomab Q1 FY26 net loss narrows to $1.8 million

• TipRanks·05/06 23:44

  Chemomab Shareholders Approve Governance Resolutions and Capital Increase at May 5 Meeting

• PUBT·05/06 22:02

  Chemomab Therapeutics holds annual shareholders meeting, re-elects directors

• TipRanks·04/28 20:28

  Chemomab Adjourns April 28 Shareholder Meeting to May 5 After Quorum Shortfall

• Reuters·04/10 20:15

  Chemomab files Form 3 for CEO and director Adi Mor George beneficial ownership

• Reuters·04/10 20:14

  Chemomab Therapeutics director Neil Cohen files initial beneficial ownership statement

• Reuters·04/10 20:10

  Chemomab files Form 3 for CFO Fatal Sigal’s initial beneficial ownership stake

• Reuters·04/10 20:09

  Chemomab files Form 3 as director Alan Moses reports beneficial ownership

• Reuters·04/10 20:05

  Chemomab files Form 3 for Chief Development Officer John Lawler

• Reuters·03/31 20:06

  Chemomab files Form 3 for director Jill Quigley’s beneficial ownership statement